Enbrel 50 MG/ML mini cartridgeml
Ended Awarded Last action
- Contract number
- SPE2DR26FX4C8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,235
Award facts
- Contract value 100% obligated
- $41,234.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,234.79 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Enbrel 50 mg/ml mini cartridges. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 7, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative plans to establish multiple regional contracts with at least three different contractors, positioning AmerisourceBergen to continue serving critical customers including the Defense Health Agency and U.S. Coast Guard through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FX4C8?
SPE2DR26FX4C8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FX4C8 worth?
The government has obligated $41,235 on SPE2DR26FX4C8.
Is contract SPE2DR26FX4C8 an order under another contract?
Yes. SPE2DR26FX4C8 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4C8 competed?
The extent of competition for SPE2DR26FX4C8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award